www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/EpiCept-Announces-New-Crolibulin-Data-Presented-at-ASCO-2013-Support-Further-Evaluation-in-Anaplastic-Thyroid-Cancer-2467439 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwmarginl2 {margin-left: 60.0px} --> </style> <!-- sh_cad_1 --> Regulatory News: <a href="/aktien/EpiCept_1-Aktie">EpiCept</a> Corporation ...http://www.finanzen.net/nachricht/EpiCept-Announces-New-Crolibulin-Data-Presented-at-ASCO-2013-Support-Further-Evaluation-in-Anaplastic-Thyroid-Cancer-2467439http://www.finanzen.net/nachricht/CEO-of-Immune-Pharmaceuticals-to-Present-at-BioEquity-Europe-2013-2446610 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwuline {text-decoration: underline} --> </style> <p class="bwalignl"> Regulatory News: <!-- sh_cad_1 --> Immune Pharmaceuticals Ltd. ...http://www.finanzen.net/nachricht/CEO-of-Immune-Pharmaceuticals-to-Present-at-BioEquity-Europe-2013-2446610http://www.finanzen.net/nachricht/EpiCept-Reports-First-Quarter-2013-Operating-and-Financial-Results-2442642 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwalignr {text-align: right} .bwcellpmargin {margin-bottom: 0px; margin-top: 0px} .bwdoublebottom {border-bottom: double black 2.25pt} .bwlistitemmargb {margin-bottom: ...http://www.finanzen.net/nachricht/EpiCept-Reports-First-Quarter-2013-Operating-and-Financial-Results-2442642http://www.finanzen.net/nachricht/EpiCept-Reports-Fourth-Quarter-and-Full-Year-2012-Operating-and-Financial-Results-2293750 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwalignr {text-align: right} .bwcellpmargin {margin-bottom: 0px; margin-top: 0px} .bwdoublebottom {border-bottom: double black 2.25pt} .bwlistitemmargb {margin-bottom: ...http://www.finanzen.net/nachricht/EpiCept-Reports-Fourth-Quarter-and-Full-Year-2012-Operating-and-Financial-Results-2293750http://www.finanzen.net/nachricht/Immune-Initiates-Bertilimumab-Phase-II-Clinical-Trial-in-Ulcerative-Colitis-2282931 <style type="text/css"> <!-- .bwalignc {text-align: center} --> </style> Regulatory News: <!-- sh_cad_1 --> Immune Pharmaceuticals Ltd. ("Immune”), a privately held Israeli company, and <a href="/aktien/EpiCept_1-Aktie">EpiCept</a> ...http://www.finanzen.net/nachricht/Immune-Initiates-Bertilimumab-Phase-II-Clinical-Trial-in-Ulcerative-Colitis-2282931http://www.finanzen.net/nachricht/EpiCept-Corporation-and-Immune-Pharmaceuticals-Amend-Merger-Agreement-2268133 <style type="text/css"> <!-- .bwalignc {text-align: center} --> </style> Regulatory News: <!-- sh_cad_1 --> Immune Pharmaceuticals Ltd. ("Immune”), a privately held Israeli company, and <a href="/aktien/EpiCept_1-Aktie">EpiCept</a> ...http://www.finanzen.net/nachricht/EpiCept-Corporation-and-Immune-Pharmaceuticals-Amend-Merger-Agreement-2268133http://www.finanzen.net/nachricht/EpiCept-Corporation-to-Present-at-the-15th-BIO-CEO-Investor-Conference-2261480 <style type="text/css"> <!-- .bwalignc {text-align: center} --> </style> Regulatory News: <!-- sh_cad_1 --> <a href="/aktien/EpiCept_1-Aktie">EpiCept</a> Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) ...http://www.finanzen.net/nachricht/EpiCept-Corporation-to-Present-at-the-15th-BIO-CEO-Investor-Conference-2261480http://www.finanzen.net/nachricht/EpiCept-Reports-Total-Shares-Outstanding-2251206 <style type="text/css"> <!-- .bwalignc {text-align: center} --> </style> Regulatory News: <!-- sh_cad_1 --> Pursuant to the requirements of the Swedish Financial Supervisory Authority, <a href="/aktien/EpiCept_1-Aktie">EpiCept</a> ...http://www.finanzen.net/nachricht/EpiCept-Reports-Total-Shares-Outstanding-2251206http://www.finanzen.net/nachricht/Daniel-Teper-of-Immune-Pharmaceuticals-to-Present-at-the-6th-Annual-OneMedForum-2218309 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} --> </style> <p class="bwalignl"> Regulatory News: <!-- sh_cad_1 --> <a href="/aktien/EpiCept_1-Aktie">EpiCept</a> Corporation (Nasdaq ...http://www.finanzen.net/nachricht/Daniel-Teper-of-Immune-Pharmaceuticals-to-Present-at-the-6th-Annual-OneMedForum-2218309http://www.finanzen.net/nachricht/EpiCept-Reports-Third-Quarter-2012-Operating-and-Financial-Results-2143883 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwalignr {text-align: right} .bwcellpmargin {margin-bottom: 0px; margin-top: 0px} .bwdoublebottom {border-bottom: double black 2.25pt} .bwlistitemmargb {margin-bottom: ...http://www.finanzen.net/nachricht/EpiCept-Reports-Third-Quarter-2012-Operating-and-Financial-Results-2143883